Company: MIRM
Filing Date: 2025-11-14
Form Type: SCHEDULE 13G/A
Source: 0000921895-25-003107
Chunk: 0

Company: Mirum Pharmaceuticals, Inc.
Filing Date: 2025-11-14
Form: SCHEDULE 13G/A
Chunk 0
---
 as to beneficial ownership of any Shares owned by another Reporting Person. BVF GP disclaims beneficial ownership of the Shares beneficially owned by BVF. BVF2 GP disclaims beneficial ownership of the Shares beneficially owned by BVF2. Partners OS disclaims beneficial ownership of the Shares beneficially owned by Trading Fund OS. BVF GPH disclaims beneficial ownership of the Shares beneficially owned by BVF and BVF2. Each of Partners, BVF Inc. and Mr. Lampert disclaims beneficial ownership of the Shares beneficially owned by BVF, BVF2 and Trading Fund OS and held in the Partners Managed Account, and the filing of this statement shall not be construed as an admission that any such person or entity is the beneficial owner of any such securities. |
| (b)     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      The following percentages are based on 50,237,647 Shares outstanding as of August 1, 2025, as disclosed in the Issuer's Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on August 6, 2025. 
 As of the close of business on September 30, 2025, (i) BVF beneficially owned approximately 1.5% of the outstanding Shares, (ii) BVF2 beneficially owned approximately 1.2% of the outstanding Shares, (iii) Trading Fund OS beneficially owned less than 1% of the outstanding Shares, (iv) BVF GP may be deemed to beneficially own approximately 1.5% of the outstanding Shares, (v) BVF2 GP may be deemed to beneficially own approximately 1.2% of the outstanding Shares, (vi) Partners OS may be deemed to beneficially own less than 1% of the outstanding Shares, (vii) BVF GPH may be deemed to beneficially own approximately 2.8% of the outstanding Shares and (viii) each of Partners, BVF Inc. and Mr. Lampert may be deemed to beneficially own approximately 3.0% of the outstanding Shares (less than 1% of the outstanding Shares are held in the Partners Managed Account). |
| (c)     |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Number of shares as to which the person has: |
|         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      See Cover Pages Items 5-9. |
|         |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      See Cover Pages Items 5-9.